UltraCon: How reliable is POCUS for pancreatic imaging?
AUSTIN, TX – Point-of-care ultrasound (POCUS) isn’t typically used for imaging the pancreas, but perhaps that should change, according to a presentation given April 7 at UltraCon.
In her talk, Alice Lee, MD, from Stanford University in California highlighted findings on how POCUS can be a reliable tool for pancreatic imaging, whether performed by experienced or novice sonographers.
“One of the big implications of pancreatic POCUS is the way that we put imaging in the hands of a provider who’s really managing the patient, whether it’s the gastroenterologist or the primary care physician,” Lee said.
Alice Lee,...
Source: AuntMinnie.com Headlines - April 7, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Ultrasound Gastrointestinal Radiology Source Type: news
Certain Pesticides Linked With Risk for Pancreatic Cancer Certain Pesticides Linked With Risk for Pancreatic Cancer
The incidence of pancreatic adenocarcinoma has been increasing steadily for more than 30 years.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 3, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Green Transition Will Drive Copper, Uranium And Lithium Higher, Says Veteran Commodity Analyst
China is no longer building fossil fuel power stations at the rate of two a week, as the world opts for greener energy options. Still, the metals needed to achieve these goals will surge again, according to Patricia Mohr, commodities expert and a former vice president at Scotiabank. Mohr told…#patriciamohr #scotiabank #melanieschaffer #pdac #mohr #panama #globalxcopperminers #globalxuranium #ura #summerspike (Source: Reuters: Health)
Source: Reuters: Health - March 24, 2024 Category: Consumer Health News Source Type: news
No OS Difference in Pancreatic Cancer With SABR vs Irreversible Electroporation
(MedPage Today) -- The use of either MRI-guided stereotactic ablative body radiotherapy (SABR) or CT-guided percutaneous irreversible electroporation after standard FOLFIRINOX chemotherapy did not result in any significant difference in overall... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - March 21, 2024 Category: Gastroenterology Source Type: news
Doctor reveals the red flag signs of 7 silent killers you might easily ignore
From pancreatic to cervical cancer, signs of seven types of the potentially deadly disease shouldn't be ignored. (Source: Daily Express - Health)
Source: Daily Express - Health - March 19, 2024 Category: Consumer Health News Source Type: news
Distinctive pathology associated with focal stenosis of the main pancreatic duct secondary to remote trauma: a long-term complication of seat belt pancreatitis - Wu AA, Thompson ED, Cameron JL, He J, Burkhart RA, Burns WR, Lafaro KJ, Shubert CR, Canto MI, Fishman EK, Hruban RH.
We present fou... (Source: SafetyLit)
Source: SafetyLit - March 16, 2024 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Cancer Treatment Focused Immuneering Faces Analyst Downgrades, Who Cite Underwhelming Solid Tumor Trial Data
Thursday, Immuneering Corporation IMRX revealed topline results from the ongoing Phase 1 portion of its Phase 1/2a trial of IMM-1-104 in advanced RAS-mutant solid tumors. Friday, shares are trading lower after several analysts downgraded the stock after the company released the data. Needham…#phase1 #imm1104 #ras #imm1104sphase #nras #needham #pfizerincs #pfemektovi #pdac #tdcowen (Source: Reuters: Health)
Source: Reuters: Health - March 15, 2024 Category: Consumer Health News Source Type: news
Study Explores Safety of Removing Inoperable Pancreatic Tumors
A clinical trial will examine if chemotherapy followed by a novel surgical procedure can improve outcomes for patients with pancreatic tumors previously considered inoperable (Source: Disabled World)
Source: Disabled World - March 15, 2024 Category: Disability Tags: Pancreatic Cancer Source Type: news
Wegovy Is Good for More Than Just Weight Loss
The obesity drug Wegovy can now claim to lower the risk of heart attack, stroke, and other cardiovascular issues in people who are overweight or who have obesity, and also have cardiovascular disease. It’s the first weight-loss drug to carry an indication for heart benefits.
The U.S. Food and Drug Administration (FDA) approved the addition to the label on March 8 based on a study from Wegovy’s manufacturer, Novo Nordisk, showing that the drug lowered the risk of heart attack, stroke, or dying of heart-related issues in this population by 20% compared to people receiving placebo.
[time-brightcove not-tgx=...
Source: TIME: Health - March 8, 2024 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
Oncolytics Biotech (NASDAQ: ONCY) (TSX: ONC) Fights Cancer With Pelareorep, Which Has Received FDA Fast Track Designation For Breast And Pancreatic Cancer
A clinical-stage immunotherapeutics company focused on oncology with the goal of helping cancer patients live longer and healthier lives may be close to bringing therapy targeting multiple cancers to licensure-enabling studies. Reporting positive clinical and translational data in 2023, Oncolytics…#fda #oncolyticsbiotech #oncolytics #translational #sabcs #sitc #goblet #mattcoffey #pelareorep #clinicalgroup (Source: Reuters: Health)
Source: Reuters: Health - March 6, 2024 Category: Consumer Health News Source Type: news
A smart molecule beats the mutation behind most pancreatic cancer
Scientists discover a new way to disarm a deadly protein that also appears in cancers of the lung, breast and colon.
UC San Francisco researchers have designed a candidate drug that could help make pancreatic cancer, which is almost always fatal, a treatable, perhaps even curable, condition.
The new molecule permanently modifies a wily cancer-causing mutation, called K-Ras G12D, that is responsible for nearly half of all pancreatic cancer cases and appears in some forms of lung, breast and colon cancer. (Source: World Pharma News)
Source: World Pharma News - March 6, 2024 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Federal industry minister Champagne slams SRG Mining ’s attempts to skirt national security review in proposed deal with China buyer
Federal Industry Minister François-Philippe Champagne says SRG Mining Inc.’s attempt to skirt a national security review around a deal to sell a stake in a critical minerals project to a Chinese buyer is far from a fait accompli. Montreal-based SRG Mining last summer announced that China-based…#srgminingincs #montreal #srgmining #lola #westafrica #middleeast #pdac #globeandmail #governmentofcanada #ottawa (Source: Reuters: Health)
Source: Reuters: Health - March 4, 2024 Category: Consumer Health News Source Type: news
Energy minister says Canada is concerned about critical metals market manipulation
Canada is concerned about market manipulation and dumping in key metals used in electric vehicle batteries, a federal Canadian minister told Reuters, adding the country wants to explore a U.S.-mooted alternative pricing model. Canada, along with Australia and the U.S., is looking to develop its…#jonathanwilkinson #pdac #wilkinson #sptsxventuremetals #baystreet #dominiquebarker #lithiumroyaltycorp #ottawa #alihaji #ionenergy (Source: Reuters: Health)
Source: Reuters: Health - March 2, 2024 Category: Consumer Health News Source Type: news
Canada concerned about critical metals market manipulation, minister says
Canada is concerned about market manipulation and dumping in key metals used in electric vehicle batteries, a federal Canadian minister told Reuters, adding the country wants to explore a U.S.-mooted alternative pricing model. Canada, along with Australia and the U.S., is looking to develop its…#jonathanwilkinson #pdac #wilkinson #sptsxventuremetals #dominiquebarker #lithiumroyaltycorp #ottawa #alihaji #ionenergy #mongolia (Source: Reuters: Health)
Source: Reuters: Health - March 2, 2024 Category: Consumer Health News Source Type: news
Fascinating interactive chart reveals how UK's cancer survival rates are lagging 15 YEARS behind the likes of Australia, Canada and Norway
Just 7.9 per cent of Brits diagnosed with pancreatic cancer in 2014 could expect to still be alive five years later. In Australia, the odds were almost double at 14.9 per cent. (Source: the Mail online | Health)
Source: the Mail online | Health - February 27, 2024 Category: Consumer Health News Source Type: news
